Gordagen Pharmaceuticals

 developing novel supplements for inflammatory diseases and cardiovascular disease...
Read more
Gordagen Pharmaceuticals Chairman & CEO: Glenn Tong

Chairman & CEO

Glenn Tong

CEO Approval Rating

68/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$5.3M

Gordagen Pharmaceuticals Competitors

1Matrix Fine Sciences
2American International Chemical, LLC
3The Vance Group
4Nexeo Solutions
5ChemPoint
6PVS

Trending Companies